Infections are a major cause of morbidity and mortality in kidney transplant recipients. To
some extent, these may be preventable. Careful pretransplant screening, immunization, and …

Renal transplant recipients have increased mortality rates when compared with the general
population. The new immunosuppressive drugs have improved short-term patient survival …

The clinical course of COVID‐19 in pediatric solid organ transplant recipients remains
ambiguous. Though preliminary experiences with adult transplant recipients have been …

The end-stage renal disease population is aging. Nearly half of all new patients are older
than 65 years and one third are older than 70 years. Assessing the possibility of …

Background Urinary tract infection (UTI) is the most common infection in renal transplant
patients, but it is necessary to determine the risk factors for bacterial UTI in recipients of other …

Early hospital readmission (EHR) is associated with increased morbidity, costs and
transition-of-care errors. We sought to quantify rates of and risk factors for EHR after kidney …

Background Modern immunosuppressive regimens after kidney transplantation usually use
a combination of two or three agents of different classes to prevent rejection and maintain …

Background. Kidney transplant recipients have higher risk of infectious diseases due to their
reliance on immunosuppression. During the current COVID-19 pandemic, some clinicians …

Chronic hepatitis C virus (HCV) infection remains an important health problem, which is
associated with deleterious consequences in kidney transplant recipients. Besides hepatic …

Introduction There are limited data pertaining to comparative outcomes of remaining on
dialysis versus kidney transplantation as the threat of coronavirus disease 2019 (COVID-19) …